Chronic Administration of Marinobufagenin in Mice Causes Hyperlocomotion and Decrease in Anxiety by Altering Monoamine Turnover Unaccompanied by Motor Deficits or Oxidative Stress

Rogneda B. Kazanskaya(St Petersburg University), Alexander V. Lopachev(Research Center of Neurology), Vassiliy Tsytsarev(Johns Hopkins University), Olga I. Kulikova(Center for Neurosciences), Аnna D. Iushina(St Petersburg University), Anna B. Volnova(Saint Louis University), Arina O. Lobaskova(St Petersburg University), Д. А. Абаимов(Center for Neurosciences)
International Journal of Molecular Sciences
June 24, 2026
Cited by 0


Related Papers